Pezzi TA, et al. - Researchers here aimed to determine the utilization rates and factors associated with chemotherapy and radiation therapy delivery for limited-stage small-cell lung cancer (SCLC) using the National Cancer Database. Observations revealed that radiation therapy or chemotherapy as part of initial treatment for limited-stage SCLC was not received by substantial proportions of patients documented in a major US cancer registry, which, in turn, was associated with poor survival. Lack of radiation therapy delivery was especially associated with government insurance coverage. This highlighted the necessity for targeted access improvement in this population.